Lexaria Bioscience Corp. | Cash Flow
Fiscal year is September-August. All values USD Thousands.
2012
2013
2015
2016
2017
2018
Net Income before Extraordinaries
251.50
343.60
1,934.40
1,277.20
1,929.50
6,609.20
Depreciation, Depletion & Amortization
456.60
343.10
-
0.60
1.50
2.30
Other Funds
1.10
40.60
479.10
277.80
683.20
4,460.10
Funds from Operations
217.50
40.10
1,455.30
998.80
1,244.80
2,146.70
Changes in Working Capital
81.60
280.90
45.70
338.00
62.40
336.40
Net Operating Cash Flow
135.90
321.00
1,501.00
660.90
1,307.20
2,483.10
Capital Expenditures
274.10
91.60
37.00
20.10
9.70
Sale of Fixed Assets & Businesses
-
21.00
721.80
-
-
Net Investing Cash Flow
274.10
70.60
684.80
20.10
9.70
Issuance/Reduction of Debt, Net
287.50
365.40
373.30
-
288.70
Net Financing Cash Flow
287.50
365.40
373.30
514.30
3,756.90
Net Change in Cash
149.30
115.00
443.00
166.70
2,439.90
Free Cash Flow
138.20
229.40
1,501.00
664.00
1,307.20
Change in Capital Stock
-
-
-
419.30
4,045.50
About Lexaria Bioscience
View Profile
